Market closed
CytoMed Therapeutics Limited/$GDTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Ticker
$GDTC
Sector
Trading on
Industry
Biotechnology
Headquarters
Singapore, Singapore
Employees
-
Website
GDTC Metrics
BasicAdvanced
$27M
-
-$0.20
-
-
Price and volume
Market cap
$27M
52-week high
$2.85
52-week low
$1.98
Average daily volume
26K
Financial strength
Current ratio
21.534
Quick ratio
19.199
Long term debt to equity
3.847
Total debt to equity
4.215
Interest coverage (TTM)
-170.36%
Management effectiveness
Return on assets (TTM)
-17.44%
Return on equity (TTM)
-26.26%
Valuation
Price to revenue (TTM)
78.929
Price to book
2.65
Price to tangible book (TTM)
2.65
Price to free cash flow (TTM)
-10.078
Growth
Revenue change (TTM)
-21.95%
Earnings per share change (TTM)
-44.74%
3-year revenue growth (CAGR)
71.93%
3-year earnings per share growth (CAGR)
-13.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CytoMed Therapeutics Limited stock?
CytoMed Therapeutics Limited (GDTC) has a market cap of $27M as of April 17, 2025.
What is the P/E ratio for CytoMed Therapeutics Limited stock?
The price to earnings (P/E) ratio for CytoMed Therapeutics Limited (GDTC) stock is 0 as of April 17, 2025.
Does CytoMed Therapeutics Limited stock pay dividends?
No, CytoMed Therapeutics Limited (GDTC) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next CytoMed Therapeutics Limited dividend payment date?
CytoMed Therapeutics Limited (GDTC) stock does not pay dividends to its shareholders.
What is the beta indicator for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited (GDTC) does not currently have a Beta indicator.